期刊文献+

慢病毒载体的改进及其在血液病基因治疗中的应用 被引量:2

Improvements of Lentiviral Vector and Its Application in Gene Therapy of Hematological Diseases
暂未订购
导出
摘要 慢病毒载体 (lentiviralvector,LV)具有可感染非分裂细胞、转移基因片段容量较大、目的基因表达时间长、不易诱发宿主免疫反应等优点 ,成为目前较有前途的病毒载体。本文以人类免疫缺陷病毒Ⅰ型 (HIV Ⅰ )为代表 。 As lentiviral vector holds the characteristics of higher transfection to non dividing cells, larger capacity of transfer gene fragments, long term expression of therapeutic gene and lower rate of immunological response, therefore it becomes potential viral vector in gene therapy. Improvements of lentiviral vector, human immunodeficiency virus type Ⅰ as example, and its application in gene transfer for gene therapy of hematological diseases are emphasized in this review.
出处 《中国实验血液学杂志》 CAS CSCD 2003年第2期208-212,共5页 Journal of Experimental Hematology
关键词 慢病毒载体 血液病 基因治疗 宿主免疫反应 人类免疫缺陷病毒I型 lentiviral vector human immunodeficiency virus type Ⅰ hematologic diseases gene therapy
  • 相关文献

参考文献27

  • 1[1]Frankel AD, Young JA. HIV-Ⅰ: fifteen proteins and an RNA. Annu Rev Biochem, 1998; 67:1-25
  • 2[2]Harrich D, Ulich C, Garcia-Martine LF, et al. Tat is required for efficient HIV-Ⅰ reverse transcription. EMBO J, 1997; 16:1224-1235
  • 3[3]Kafri T, Blomer U, Peterson DA, et al. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat Genet, 1997; 17:314-317
  • 4[4]Higashikawa F, Chang L. Kinetic analyses of stability of simple and complex retroviral vectors. Virology, 2001; 280:124-131
  • 5[5]Haas DL, Case SS, Crooks GM, et al. Critical factors influencing stable transduction of human CD34(+) cells with HIV-Ⅰ-derived lentiviral vectors. Mol Ther, 2000; 2:71-80
  • 6[6]Uchida N, Sutton RE, Friera AM, et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci USA, 1998;95:11939-11944
  • 7[7]Naldini L, Blomer U, Gage FH, et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA, 1996; 93:11382-11388
  • 8[8]Miyoshi H, Takahashi M, Gage FH, et al. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA, 1997; 94:10319-10323
  • 9[9]Iwakuma T, Cui Y, Chang LJ, et al. Self-inactivating lentiviral vectors with U3 and U5 modifications. Virology, 1999; 261:120-132
  • 10[10]Miyoshi H, Blomer U, Takahashi M, et al. Development of a self-inactiviating lentivirus vector. J Virol, 1998; 72:8150-8157

同被引文献33

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部